Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma

Card image cap

In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more than half of surgical specimens taken from patients who had been treated with neoadjuvant (pre-operative) pembrolizumab.

Related Keywords

Michigan , United States , Madrid , Spain , Utah , Texas , Kenilworth , Northwell , Michaelc Lowe , Kaiser Permanente , Elizabethi Buchbinder , Megan Othus , G Paul Wright , Vernonk Sondak , Antoni Ribas , Sapnap Patel , Larissa Korde , Phyllis Gyorkey , Sunandana Chandra , Victorg Prieto , Megan Craig , John Hyngstrom , Ankit Mangla , Elad Sharon , Craig Devoe , Thach Giao Truong , Aparna Hegde , Kari Kendra , Johnm Kirkwood , Samantha Guild , Merck Co Inc , Ohio State University Wexner Medical Center , University Hospitals Seidman Cancer Center , University Of Alabama , Dana Farber Cancer Institute Harvard Center , University Of Texas Md Anderson Cancer Center , Spectrum Health , Northwell Health Cancer Institute , Emory University , Moffitt Cancer Center , University Of Michigan , Development Agreement , National Institutes Of Health , Cancer Research Consortium Of West Michigan , National Clinical Trials Network , Valerie Guild , Jonsson Comprehensive Cancer Center , National Cancer Institute Therapy Evaluation Program , Cleveland Clinic Foundation , University Of Utah Huntsman Cancer Institute , Data Management Center , Northwestern University , Cancer Research Network , European Society Of Medical Oncology , National Cancer Institute , European Society , Medical Oncology , New England Journal , Phyllis Gyorkey Chair , National Institutes , Research Network , Clinical Trials Network , Cooperative Research , Cancer Research Consortium , West Michigan , Utah Huntsman Cancer Institute , Christopher Lao , Dana Farber Cancer , Harvard Cancer Center , Pittsburgh Medical Center Hillman Cancer , James Moon , Melanoma , Dancer , Cancer Therapy , Clinical Trial , Immune System , Immunotherapy , Lymph Node , Ncology , Research , Surgery , Humor ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.